Copperion
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Cor Group
Cor Group is a Finnish company family focused on innovating in the health and well-being sector. Their strategy revolves around acquiring and nurturing companies, providing them with the autonomy and resources needed for growth and development. They prioritize long-term value creation over short-term gains, aiming to build sustainable businesses rather than selling them off quickly. They operate as a holding company or a parent company, acquiring smaller to medium sized operators in the health and wellbeing space. Cor Group emphasizes a decentralized model, empowering its subsidiaries with the freedom to innovate and grow. They provide support and resources to foster development, while maintaining a long-term vision of building enduring businesses. This approach has enabled them to grow into a substantial group with a significant revenue base. Their focus on employee satisfaction and continuous improvement underscores their commitment to delivering high-quality services to customers. The company invests heavily in its employees, recognizing them as a key asset. They foster an environment of internal entrepreneurship, which is essential for navigating the dynamic landscape of a multi-industry group. This approach is balanced by a commitment to employee well-being and support. They consider themselves a consolidator in the space. Cor Group's investment strategy involves acquiring businesses across Finland, indicating a strategic approach to expanding their presence and market share within the country. They are already a very large operator in Finland, suggesting a position where additional consolidation will raise anti-trust/competition concerns.
Cor Group Oy
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Core Angels
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Core Angels Porto
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Cornwall & Isles of Scilly Investment Fund (CIOSIF)
The Cornwall & Isles of Scilly Investment Fund (CIOSIF) was an initiative launched by the government-owned British Business Bank, supported by the European Regional Development Fund. Launched in February 2017, it completed its investment phase in December 2023, facilitating over £200m of direct and private sector co-investment to growing companies across the South West. CIOSIF aimed to transform the finance landscape for smaller businesses in the Cornwall and Isles of Scilly region and foster economic growth through enterprise, targeting SMEs with commercial debt and equity finance ranging from £25,000 to £2 million to support their growth and job creation. The fund addressed barriers to accessing finance and an equity gap in start-up, early stage, and development capital, specifically tailored for small businesses across the region. It offered a mix of debt and equity funding to SMEs at various stages of development, utilizing a combination of ERDF, LEP, and HMG grant funding. Although CIOSIF has completed its investment phase, the region continues to be served by the South West Investment Fund, which launched in July 2023 and is open to investments. The new fund aims to deliver £200m of investment to growing companies, building on CIOSIF's legacy of supporting businesses through debt and equity financing. The investment strategy included both debt and equity options, recognizing the different needs of businesses whether for working capital, rapid growth, or longer-term backing.
Cornwall and Isles of Scilly Investment Fund (CIOSIF)
The Cornwall and Isles of Scilly Investment Fund (CIOSIF) aimed to transform the finance landscape for smaller businesses in the Cornwall and Isles of Scilly region and to realize the region’s potential to achieve economic growth through enterprise. The fund provided commercially focused finance through a Debt and Equity Fund. It addressed the equity gap in start-up, early-stage, and development capital for SMEs in the region. The investment phase for CIOSIF concluded in December 2023, but the fund facilitated over £200m of direct and private sector co-investment to growing companies across the South West during its operational period. CIOSIF was a collaboration between the British Business Bank and the Cornwall & Isles of Scilly Local Enterprise Partnership (CIOS LEP). The up to £40m Fund supported access to finance where barriers existed for SMEs. The funding was drawn from several sources including the UK Government and the European Regional Development Fund, including an allocation from the Cornwall and Isles of Scilly Local Enterprise Partnership (CIOS LEP). CIOSIF has transitioned to the South West Investment Fund, which launched in July 2023 and is now open for investments. The new South West Investment Fund will deliver £200m of investment to growing companies. It is intended to continue supporting the growth of companies across the South West region by offering both debt and equity financing options.
Corporación Cervino
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Corporatum
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Corsair Capital LLC
Corsair Capital is a specialist investment firm that provides opportunities for investors and solutions for companies through its Buyouts and Infrastructure platforms. They aim to be more than financial investors, positioning themselves as active partners engaged in their portfolio companies' success. Their investments are designed to address the specific challenges of shareholders and management teams while fostering new growth opportunities. In the Buyouts space, Corsair focuses on growing companies in North America and Europe that operate at the forefront of the evolving financial services industry. They seek businesses that serve as essential partners to their customers. Corsair leverages deep sectoral expertise and traditional equity sponsorship to offer a unique investment proposition in infrastructure. The firm targets value-added infrastructure businesses. The firm emphasizes responsible investing, with specific objectives and policies tailored to both Buyouts and Infrastructure investments. They are also compliant with EU SFDR regulations. This commitment underscores a focus on sustainable and ethical investment practices. Corsair blends operational expertise with traditional equity sponsorship in their infrastructure platform, targeting value-added infrastructure businesses with a commitment to responsible investing.
Cortes Capital
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Corteva
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Corundum Systems Biology
Corundum Systems Biology (CSB) believes that the future of health innovation lies in systems-level thinking and data-driven discovery. They focus on advancing the science of complexity by investing in disruptive ideas, foundational platforms, and early-stage ventures. Their vision is to decode human biology in real-time to keep people healthier, longer, achieved through the convergence of human-driven data, high-throughput technologies, and computational intelligence. CSB aims to pioneer predictive, preventative, and personalized health solutions at scale by supporting transformative breakthroughs in systems biology and addressing the complexity of life itself.
CosmiCapital
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Cottonwood
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Cottonwood Technology Fund
Focuses on disruptive deep tech innovations in key enabling technologies, excluding consumer products, software, AI, platforms, apps, crypto, and pharma/drug development. Geographically focused on Southwest USA and Northwest Europe.
Counterview Capital
Counterview Capital is a New York-based venture capital firm that focuses on pre-seed and seed stage technology companies. They aim to partner with creative and unconventional thinkers who are building innovative products intended to change the world. The firm has a "counter view" towards venture capital, and they seek founders who similarly challenge the status quo.
Course Corrected VC
Course Corrected VC is a venture capital firm focused on early-stage climate positive technology companies. Founded in 2021 and based in Stockholm, Sweden, the firm is dedicated to supporting entrepreneurs who are developing innovative solutions to address climate change with a commercial approach. The firm is founded by three female GPs with long-standing Venture Capital investing experience and deep expertise in the climate tech sector. Course Corrected aims to partner with visionary and passionate entrepreneurs to solve pressing climate challenges. They back outstanding entrepreneurs and teams with fast-growing and scalable businesses that drive the transformation towards climate-positive alternatives, disrupt incumbents, and have the potential to become leaders in their respective markets. Their approach emphasizes commercial viability alongside climate impact.
Covéa
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Cowen Healthcare Investments
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Cradle
Cradle is building a platform that leverages AI to accelerate protein engineering and discovery for biopharma and industrial bio R&D teams. Their platform aims to reduce development time and improve the properties of protein candidates, leading to more breakthroughs with fewer experiments. This is achieved by generating protein candidates, tracking the experimental process, and managing data effectively, enabling a more efficient and data-driven approach to biological innovation. Cradle's core value proposition is to make biology programmable, allowing scientists to decode and rewrite biological systems to unlock new food sources, materials, and therapeutics. The company focuses on partnering with top biopharma companies and industrial bio R&D teams, embedding advanced AI directly into their innovation processes. By doing so, Cradle enables these teams to shorten development time and bring real-world biosolutions faster to market. Cradle’s platform facilitates the generation of candidates, data management, and report exploration, effectively serving as a comprehensive AI-powered tool for protein engineering. Cradle is addressing the critical need for faster and more efficient protein engineering by creating an integrated solution that encompasses candidate generation, experimental data management, and reporting. This approach streamlines the traditionally complex and lengthy process of protein design and optimization, allowing their customers to achieve significant improvements in development time and efficacy. The company's platform is validated through customer testimonials and case studies, demonstrating tangible benefits such as enhanced binding affinity and faster enzyme design.
Crane Earth
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Cranfield University Seed Fund
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Creades
Creades is a long-term and engaged owner focused on creating value alongside entrepreneurs and company leaders. They aim to achieve this by creatively rethinking, challenging, restructuring, and developing both listed and unlisted companies. The firm's approach involves actively participating in the growth and evolution of their portfolio companies, suggesting a hands-on and collaborative investment style. Their focus on both listed and unlisted companies indicates a flexible investment strategy, potentially allowing them to invest across various stages of a company's lifecycle. Creades seems to emphasize active ownership and creating value through operational improvements and strategic shifts, rather than purely financial engineering.